Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Changes of Stockholders' Equity, as Adjusted

v3.24.3
Condensed Statements of Changes of Stockholders' Equity, as Adjusted - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Total
Balances, Beginning at Dec. 31, 2022 $ 73 $ 63,499,628 $ (56,173,207)   $ 7,326,494
Balances, Beginning (in shares) at Dec. 31, 2022 733,215        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense   161,697     161,697
Net loss     (1,516,864)   (1,516,864)
Balances, Ending at Mar. 31, 2023 $ 73 63,661,325 (57,690,071)   5,971,327
Balances, Ending (in shares) at Mar. 31, 2023 733,215        
Balances, Beginning at Dec. 31, 2022 $ 73 63,499,628 (56,173,207)   7,326,494
Balances, Beginning (in shares) at Dec. 31, 2022 733,215        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (4,192,842)
Balances, Ending at Sep. 30, 2023 $ 77 65,426,861 (60,366,049) $ (299,128) 4,761,761
Balances, Ending (in shares) at Sep. 30, 2023 770,317        
Balances, Beginning at Mar. 31, 2023 $ 73 63,661,325 (57,690,071)   5,971,327
Balances, Beginning (in shares) at Mar. 31, 2023 733,215        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of warrants $ 2 292,253     292,255
Exercise of warrants (in shares) 18,705        
Shares surrendered in cashless warrant exercises $ (1)     (292,254) (292,255)
Shares surrendered in cashless warrant exercises (in shares) (7,582)        
Share-based compensation expense   161,664     161,664
Net loss     (1,440,904)   (1,440,904)
Balances, Ending at Jun. 30, 2023 $ 74 64,115,242 (59,130,975) (292,254) 4,692,087
Balances, Ending (in shares) at Jun. 30, 2023 744,338        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares under Sales Agreement, net of costs $ 3 1,156,440     1,156,443
Issuance of common shares under Sales Agreement, net of costs (shares) 25,675        
Exercise of warrants   6,874     6,874
Exercise of warrants (in shares) 440        
Shares surrendered in cashless warrant exercises       (6,874) (6,874)
Shares surrendered in cashless warrant exercises (in shares) (136)        
Share-based compensation expense   148,305     148,305
Net loss     (1,235,074)   (1,235,074)
Balances, Ending at Sep. 30, 2023 $ 77 65,426,861 (60,366,049) (299,128) 4,761,761
Balances, Ending (in shares) at Sep. 30, 2023 770,317        
Balances, Beginning at Dec. 31, 2023 $ 77 65,575,167 (61,469,222) (299,128) 3,806,894
Balances, Beginning (in shares) at Dec. 31, 2023 770,317        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense   138,969     138,969
Net loss     (1,291,335)   (1,291,335)
Balances, Ending at Mar. 31, 2024 $ 77 65,714,136 (62,760,557) (299,128) 2,654,528
Balances, Ending (in shares) at Mar. 31, 2024 770,317        
Balances, Beginning at Dec. 31, 2023 $ 77 65,575,167 (61,469,222) (299,128) 3,806,894
Balances, Beginning (in shares) at Dec. 31, 2023 770,317        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (4,621,852)
Balances, Ending at Sep. 30, 2024 $ 111 67,339,522 (66,091,074) (299,128) 949,431
Balances, Ending (in shares) at Sep. 30, 2024 1,110,317        
Balances, Beginning at Mar. 31, 2024 $ 77 65,714,136 (62,760,557) (299,128) 2,654,528
Balances, Beginning (in shares) at Mar. 31, 2024 770,317        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Proceeds from public offering of common stock, net of offering costs $ 34 1,382,136     1,382,170
Proceeds from public offering of common stock, net of offering costs (shares) 340,000        
Share-based compensation expense   148,948     148,948
Net loss     (1,049,833)   (1,049,833)
Balances, Ending at Jun. 30, 2024 $ 111 67,245,220 (63,810,390) (299,128) 3,135,813
Balances, Ending (in shares) at Jun. 30, 2024 1,110,317        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation expense   94,302     94,302
Net loss     (2,280,684)   (2,280,684)
Balances, Ending at Sep. 30, 2024 $ 111 $ 67,339,522 $ (66,091,074) $ (299,128) $ 949,431
Balances, Ending (in shares) at Sep. 30, 2024 1,110,317